Drug Trial Radar · NCT06371417
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
144
Planned (sponsor's estimate)
Start
Aug 19, 2024
Primary completion
Mar 31, 2027
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- Chugai PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Apr 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of classical complement pathway, after multiple dose administration in patients with immunological diseases such as antiphospholipid syndrome (APS), bullous pemphigoid (BP), Behçet's Syndrome (BS), dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM) and immune thrombocytopenia (ITP).
Conditions
- Antiphospholipid Syndrome (APS)
- Bullous Pemphigoid (BP)
- Behçet's Syndrome (BS)
- Dermatomyositis (DM)
- Immune-mediated Necrotizing Myopathy (IMNM)
- Immune Thrombocytopenia (ITP)
Interventions
RAY121Drug
Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse events (AEs)Time frame: Baseline to Week 32
Locations
77 sites in 20 countries. Site status is shown where the registry gives one.
University of California-Irvine
Orange, California · Recruiting
Johns Hopkins University
Baltimore, Maryland · Recruiting
Northwell Health, LLC PRIME
Lake Success, New York · Withdrawn
Hospital for Special Surgery
New York, New York · Withdrawn
Universtity of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
Ohio State University
Columbus, Ohio · Withdrawn
Oregon Health & Science University
Portland, Oregon · Recruiting
University of Pennsylvania, Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania · Recruiting
Amarillo Center for Clinical Research
Amarillo, Texas · Withdrawn
Austin Neuromuscular Center
Austin, Texas · Recruiting
Nerve and Muscle Center of Texas
Houston, Texas · Recruiting
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia · Recruiting
Westmead Hospital
Sydney, New South Wales, Australia · Recruiting
Campbelltown Public Hospital
Sydney, New South Wales, Australia · Recruiting
The Alfred Hospital
Melbourne, Victoria, Australia · Recruiting
Box Hill Hospital
Melbourne, Victoria, Australia · Recruiting
AKH - Medizinische Universitaet Wien, Abteilung fuer Klinische Pharmakologie
Vienna, Austria · Withdrawn
Diagnostic Consultation Center CONVEX EOOD
Sofia, Sofia City Province, Bulgaria · Withdrawn
UMHAT Sv Ivan Rilski EAD
Sofia, Sofia City Province, Bulgaria · Recruiting
"SHATHD" EAD Sofia
Sofia, Sofia City Province, Bulgaria · Not yet recruiting
UMHAT "Prof. Dr. St. Kirkovich", AD
Stara Zagora, Stara Zagora Province, Bulgaria · Not yet recruiting
University of Alberta Hospital - Department of Anesthesiology and Pain Medicine
Edmonton, Alberta, Canada · Recruiting
University of Alberta Hospital - Dermatology
Edmonton, Alberta, Canada · Recruiting
The Royal Institution for the Advancement of Learning/McGill University
Montreal, Quebec, Canada · Recruiting
Centre de Rhumatologie de l'Est du Quebec
Rimouski, Quebec, Canada · Recruiting
DIEX Recherche Sherbrooke Inc.
Sherbrooke, Quebec, Canada · Recruiting
Clinical Hospital Center "Sestre Milosrdnice"
Zagreb, City of Zagreb, Croatia · Recruiting
University hospital centre Zagreb
Zagreb, City of Zagreb, Croatia · Not yet recruiting
Specialty Hospital Medico
Rijeka, Primorje-Gorski Kotar County, Croatia · Withdrawn
Sanatorium Profesora Arenbergera
Prague, Prague, Czechia · Withdrawn
AP-HP Hôpital Universitaire Pitié Salpêtrière
Paris, Île-de-France Region, France · Recruiting
Hopital Lapeyronie,Service d'Immuno Rhumatologie
Montpellier, Occitanie, France · Recruiting
Universitaetsklinikum Tuebingen
Tübingen, Baden-Wurttemberg, Germany · Not yet recruiting
Universitaetsklinikum Erlangen
Erlangen, Bavaria, Germany · Not yet recruiting
Immanuel Klinik Rudersdorf
Rüdersdorf, Brandenburg, Germany · Recruiting
Universitaetsklinikum Carl Gustav Carus TU Dresden, Klinik und Poliklinik f. Dermatologie
Sachsen, Bundesländer, Germany · Not yet recruiting
Universitaetsmedizin Goettingen
Göttingen, Göttingen District, Germany · Withdrawn
Universitaetsklinikum Schleswig Holstein - Campus Luebeck, Klinik f Dermatologie, Allergologie u Venerologie
Lübeck, Schleswig-Holstein, Germany · Withdrawn
Semmelweis Egyetem
Budapest, Hungary · Recruiting
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont
Szeged, Csongrád-Csanád County, Hungary · Not yet recruiting
Showing 40 of 77 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.